Gout drug Colchicine to be tested as COVID-19 treatment in UK trial

The RECOVERY trial, which is world’s largest clinical trial of treatments for patients hospitalised with COVID-19, will randomly allocate at least 2,500 patients recruited to receive the anti-inflammatory colchicine, as inflammation is considered to play a major role in COVID-19.

Source:

Reuters Health